Gx 623    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
135Aicardi syndrome1

135. Aicardi syndrome    [ 1 clinical trial,   9 drugs,   (DrugBank: 3 drugs),   0 drug target gene,   0 drug target pathway]
Searched query = "Aicardi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-002710-23-FR
(EUCTR)
18/06/2015N/AN/A - AGS
MedDRA version: 18.0;Level: PT;Classification code 10054935;Term: Aicardi's syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Trade Name: Zidovudine
Product Name: Zidovudine
Product Code: J05A F01
INN or Proposed INN: Zidovudine
Other descriptive name: retrovir
Trade Name: lamivudine
Product Name: lamivudine
Product Code: GX CJ7
INN or Proposed INN: lamivudine
Other descriptive name: epivir
Trade Name: Abacavir
Product Name: Abacavir
Product Code: GX 623
INN or Proposed INN: abacavir
Other descriptive name: ziagen
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNot RecruitingFemale: yes
Male: yes
24Phase 2France